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Non-invasive diagnosis of coronary artery disease using
cardiogoniometry performed at rest
Abstract
PRINCIPLES: Cardiogoniometry is a non-invasive technique for quantitative three-dimensional
vectorial analysis of myocardial depolarization and repolarization. We describe a method of surface
electrophysiological cardiac assessment using cardiogoniometry performed at rest to detect variables
helpful in identifying coronary artery disease. METHODS: Cardiogoniometry was performed in 793
patients prior to diagnostic coronary angiography. Using 13 variables in men and 10 in women, values
from 461 patients were retrospectively analyzed to obtain a diagnostic score that would identify patients
having coronary artery disease. This score was then prospectively validated on 332 patients. RESULTS:
Cardiogoniometry showed a prospective diagnostic sensitivity of 64%, and a specificity of 82%. ECG
diagnostic sensitivity was significantly lower, with 53% and a similar specificity of 75%.
CONCLUSIONS: Cardiogoniometry is a new, noninvasive, quantitative electrodiagnostic technique
which is helpful in identifying patients with coronary artery disease. It can easily be performed at rest
and delivers an accurate, automated diagnostic score.
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Principles: Cardiogoniometry is a non-inva-
sive technique for quantitative three-dimensional
vectorial analysis of myocardial depolarization
and repolarization. We describe a method of sur-
face electrophysiological cardiac assessment using
cardiogoniometry performed at rest to detect
variables helpful in identifying coronary artery
disease.
Methods: Cardiogoniometry was performed in
793 patients prior to diagnostic coronary angio -
graphy. Using 13 variables in men and 10 in
women, values from 461 patients were retrospec-
tively analyzed to obtain a diagnostic score that
would identify patients having coronary artery
disease. This score was then prospectively vali-
dated on 332 patients.
Results: Cardiogoniometry showed a prospec-
tive diagnostic sensitivity of 64%, and a specificity
of 82%. ECG diagnostic sensitivity was signifi-
cantly lower, with 53% and a similar specificity of
75%.
Conclusions: Cardiogoniometry is a new, non-
invasive, quantitative electrodiagnostic technique
which is helpful in identifying patients with coro-
nary artery disease. It can easily be performed at
rest and delivers an accurate, automated diagnos-
tic score.
Key words: coronary artery disease; myocardial is-
chemia; cardiogoniometry; electrodiagnosis
Summary
Open my eyes that I may see wonderful things 
in your law (Ps. 119:18)
Since the late 1930s, assessments of three-di-
mensional data have been undertaken in order to
glean information about the heart dipole [1, 2];
many different techniques have been suggested
[3]. The best known and most widely – even
though rarely – used vectorcardiography is the
method developed by Frank [4]. However, tradi-
tional vectorcardiography is complicated to
record, uses projections oriented according to
body planes rather than the heart and electrode
placement does not ensure an orthogonal system.
We have developed a simple-to-use vectorcardio-
graphic method, cardiogoniometry (CGM),
which can surmount these traditional drawbacks
and may provide easily accessible and useful
quantitative information concerning the condi-
tion of the heart. CGM is a non-invasive, vecto-
Introduction
Abbreviations
CAD coronary artery disease
CGM cardiogoniometry
ECG electrocardiogram
IHD ischaemic heart disease
LAD left anterior descending coronary artery
LCX left circumflex coronary artery
OSP oblique sagittal plane
RCA right coronary artery
SD standard deviation
CMP cardiomyopathy
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rial, digital analysis of myocardial depolarization
and repolarization. Its principles have been de-
scribed earlier [5] and, in studies with smaller pa-
tient numbers [6–8], it has been shown to be use-
ful in diagnosing ischaemic heart disease (IHD).
However, only the recent advances in electronic
data analysis have enabled the development of
CGM into the new, non-invasive and automated
cardiological diagnostic method presented here.
CGM uses four thoracic leads to construct the
vectorcardiographic loops in a three-dimensional
system, defined by the three orthogonal axes, x, y,
and z, approximatively related to the anatomical
orientation of the heart.
Traditional 12-lead surface electrocardiogra-
phy, performed at rest, is a non-invasive and
widely available, albeit insensitive method for di-
agnosing ischaemic heart disease [9]. Further-
more, automated interpretation of the ECG is
not always reliable [10] and the diagnostic yield
depends highly on the ECG expertise of the
reader [11]. We hypothesized that CGM can de-
tect changes in the electric cardiac phenomena,
even at rest, in patients at risk for myocardial 
ischaemia. The rationale for this is threefold: 
1) CGM provides three-dimensional information
on voltage and spatial orientation of the summa-
tion vector of the surface potential, which is not
available in the ECG; 2) CGM provides measured
quantitative computer analysis of this three-
dimensional information; the rating does not re-
quire a qualitative evaluation by an expert; and 3)
the CGM allows spatial analysis of beat-to-beat
variability.
Patients and methods
Due to suspected ischaemic heart disease, 793 (270
women) patients were referred to a tertiary care cardiol-
ogy clinic for a first elective coronary angiography. The
CGM was performed at rest a few hours prior to the
coronary angiogram. Written informed consent was ob-
tained from all patients, and the local Ethics Committee
had approved the study. During the recording, the patient
lay in a supine position and, after normal expiration, held
his or her breath for 12 to 15 seconds during the meas-
urement. If this was not possible, shallow breathing with
minimal thoracic excursion was allowed. Patients with
atrial fibrillation, with frequent premature beats in the
recording, left bundle branch block, and severe (grade III)
valvular heart disease were excluded, as were patients with
previous cardiac surgery. A CGM score to identify pa-
tients with coronary artery disease (CAD) was retrospec-
tively derived on 461 patients (154 women) and prospec-
tively validated on a further 332 patients (116 women). In
145 consecutive patients (51 women), the pre-angiogra-
phy ECG was evaluated by an independent cardiologist
(P.L.) for the presence or absence of IHD in the retro-
spective cohort. The same cardiologist, who had been
blinded to the results of the CGM and coronary angiog-
raphy, rated the pre-angiography ECG in all patients
from the prospective cohort. Sensitivity and specificity of
CGM and ECG in the prospective cohort were statisti-
cally compared using McNemar’s test. Tests of differences
between accuracies were constructed under Gaussian as-
Figure 1
Principles of cardiogoniometry: Four electrodes are placed at four points on the patient’s thorax as follows: Point 1 (green) 
at point V4 of Wilson, ie, in the 5th intercostal space in the mid-clavicular line; point 2 (white) sagittal to electrode 1 on the back
(point V8 of Wilson); point 3 (yellow) is located perpendicularly above electrode 1 at 0.7 times the distance between points 1
and 2; point 4 (red) is placed to the right of point 3 at the same distance as between points 1 and 3. The leads are  defined as
follows: 4-2 D (dorsal), 4-1 A (anterior), 2-1 I (inferior), 4-3 Ho (horizontal), 3-1 Ve (vertical). Points 4-2-1 define the oblique
sagittal plane OSP (red on the right drawing); points 4-3-1 define the frontal plane (yellow on the right drawing). The third
plane (blue on the right drawing) is orthogonal to the two other planes and contains point 3; it is the sagittal plane perpendi-
cular to the OSP. Projection x is oriented in an antero-dorsal direction and lies in the OSP and the sagittal plane perpendicular
to the OSP. Projection y is oriented in a baso-apical direction and lies in the OSP (4-2-1) and the frontal plane (4-3-1). Projec-
tion z is oriented in a supero-inferior direction relative to the OSP and lies in the frontal plane (4-3-1) and the sagittal plane
perpendicular to the OSP. Deduction of definitions of the projections x, y, and z is given elsewhere in detail [5].
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ymptotic assumptions and relied upon the variances of
the differences in sensitivities and specificities. A p-value
<0.05 was considered significant.
Principles of cardiogoniometry
The trigonometric principles of CGM have been
described in detail elsewhere [5], but can be summarized
as follows: Four electrodes define two planes that are per-
pendicular to each other (figure 1): the frontal plane
(electrodes 1,3,4) and the oblique sagittal plane (OSP)
(electrodes 1,2,4). The three electrodes for each plane de-
scribe a Kirchhoff loop. Vectorial addition of the three
potentials between pairs of these electrodes results in a
vector that describes the electric field in each plane, ac-
cording to Newton. The vectors of two orthogonal
planes allow the construction of the heart vector, which
gives, by its orientation, the direction of the field and, by
its length, the strength of the electrical field generated by
the heart. The electrical potential sampling rate was 
1 kHz. CGM differs from conventional vectorcardiogra-
phy by two relevant improvements. Firstly, the record-
ings are performed without intercalated resistances. This
avoids the distortions present in historical vectorcardio-
graphic methods using circuits with compensatory resist-
ances. No distorting proximity effects were observed.
Secondly, the projection planes of CGM are oriented in
rough approximation to the anatomy of the heart, rather
than the body planes (figure 2).
The coordinate system used for display is a Carte-
sian system (figures 2 and 3), defined by three orthogonal
axes that cross in the origin, which has the value of zero
for all axes (figure 2). The x-axis has an antero-posterior
orientation with positive values posteriorly. The y-axis
has a left oblique sagittal orientation (OSP) with positive
values pointing to the apex, negative values pointing to
the base of the heart. The x- and y-axes define the OSP,
which is the main plane. The z-axis is perpendicular to
the OSP with negative values pointing up. The frontal
plane is defined by the y- and the z-axes. The plane that is
defined by the x- and z-axes is also a sagittal plane that
lies perpendicular to the OSP and separates the apical
from the basal part of the heart.
The recording of the vector each millisecond results
in the three traces x, y, and z (figure 4) from which the
vector loops (figure 5) are constructed. The distance of
each point on the different loops from the origin, ie, the
length of each millisecond vector that corresponds to the
strength of the electrical field, can be displayed over time.
Figure 2
Projections x, y, and z. The projections x, y, and z are oriented relative to the heart. The OSP (red in the drawing) is the main
plane, defined by the projections x and y. A globe is defined around the heart, with its centre at the origin of the orthogonal
system, ie, at the point where the three rectangular axes x, y, and z cross. Degrees of longitude (angle alpha) and of latitude
(angle beta) define precisely every point on the globe around the heart. The positive end of the y-axis projects to the apex of
the heart and pierces the  imaginary globe at b = 0° latitude and a = 90° longitude. The  negative end of the y-axis lies at b = 0°
latitude and a = –90°  longitude. The spatial orientation of any vector measured can be defined with its projection onto the
globe positioned around the heart.
Figure 3
The coordinate system of the heart vectors enables the
imaginary globe around the heart to be divided into hemi-
spheres and octants. The apical hemisphere (orange) is lo-
cated between 0° and 180° longitude (angle alpha), the basal
hemisphere correspondingly between 0° and –180°. The 
y-axis points to the apex of the heart and therefore to 
a = 90° longitude and b = 0° latitude. The anterior (ventral)
hemisphere extends from a = 90° over 180° to –90°, and the 
posterior (dorsal) hemisphere correspondingly from a = 90°
over 0° to –90°. The latitude (angle beta) defines a superior
(b = 0° – –90°) and an inferior (b = 0° – +90°) hemisphere. The
octants are defined as follows: octant 1: apical inferior pos-
terior; octant 2: apical inferior anterior; octant 3: apical supe-
rior posterior; octant 4: apical superior anterior; octant 5:
basal inferior posterior; octant 6: basal inferior anterior; 
octant 7: basal superior posterior; octant 8: basal superior
anterior. Numbers of apical octants are given in red; 
numbers of basal octants are given in purple.
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Figure 4
Traces from a healthy person (left) and a patient with myocardial ischaemia (right). Images above show the recordings of the projections of x (dorsal –
ventral), y (apical – basal), and z (below – above). Images below show the time course of the median potential corresponding to the median distance 
of the tip of the momentary vector from the origin (abscissa in mV). Dark colours indicate potentials from the beginning of a loop to the maximum 
distance from the origin; light colours correspond to potentials from the maximum of the loop till its end. Potentials corresponding to the P-loop (atrial 
depolarisation) are shown in grey (P+ dark grey, P- light grey). Because potentials are non-vectorial and cannot be negative, the loop corresponding 
to the QRS-complex is designated the R-loop. The potentials corresponding to the R-loop (ventricular depolarisation) are shown in blue (R+ dark blue, 
R- light blue). The potentials measured after the end of the R-loop and before the onset of the T-loop are shown in red. The potentials corresponding to
the T-loop (ventricular repolarisation) are shown in green (T+ dark green, T- light green). TP-potentials are shown in purple. The recording on the left side
differentiates U-potentials (U+ orange, U- yellow).
Figure 5
Vector loops and projections from a healthy person (left) and a patient with myocardial ischaemia (right). The images above show three orthogonal
 projections of the vector loops of several heart beats onto one plane: The loops on the left are the projection onto the OSP. The loops in the middle are
the projection onto the sagittal plane perpendicular to the OSP, corresponding to the view onto the apex (four chamber projection in echocardiogra-
phy). The loops on the right are the projection onto the frontal plane. Axes and projections of octant numbers are shown in black; P-loop in grey, R-loop
in blue, RT-potentials in red, T-loop in green, TP-potentials are not shown. Note the pathological variability of the loops from heartbeat to heartbeat
(“floating”) in the patient on the right side. The images below show the projection of the maximal vector of each R-loop (blue) and T-loop (green) 
onto the globe around the heart. Note the pathological orientation of the maximal T-vectors (basal, inferior, anterior) in the patient on the right side.
 Numbers of octants are indicated in grey. Percentages of R-loop (blue) and T-loop (green) potentials are shown for each octant.
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Name M / F Description Normal range
P20 F Ratio of the maximal spatial velocity of the R-loop over the maximal spatial velocity of the ≤22.5
T-loop. “Spatial velocity” is defined as the maximal distance measured in mV between two 
points separated from each other by 10 ms temporal distance on the R-loop or the T-loop, 
respectively.
P46 F Median value of the angle alpha of the maximal vector of the R-loop ≤90°  
P49 M Median value of the angle beta of the maximal vector of the R-loop ≥–38°
P51 M SD of the angle beta of the maximal vector of the R-loop for all measured heartbeats ≤2.15°  
P64 M / F Median angle alpha of the maximal vector of the T-loop M: 10° – 130°; F: ≤113°  
P67 M / F Median angle beta of the maximal vector of the T loop M: –56° – 1°; F: ≤1°
P72 M SD for all measured heartbeats of the angle phi, defined as the angle between the maximal ≤5.2°
vectors of the R-loop and the T-loop
P90 M SD for all measured heartbeats of the ratio of the maximal potential (ie, the length of the ≤0.09
maximal vector) of the P-loop over the maximal potential of the T-loop
P108 M SD for all measured heartbeats of the “eccentricity” variable that describes the roundness ≤0.08
of the R loop. If the R-loop is a perfect circle, P108 equals 0.
P127 M % of the potential of the R-loop located in the apical superior anterior octant, ie, octant 4 ≤51%
P136* M % of the potential of the R-loop located in the basal superior posterior octant, ie, octant 7 ≤47%
P154 M / F % of the potential of the T-loop located in the basal inferior posterior octant, ie, octant 5 M:≤1.25%; F: ≤19%
P157 M % of the potential of the T-loop located in the basal inferior anterior octant, ie, octant 6 ≤11%  
P176 F Temporal integral of the potential of the P-loop after the maximum of P ≤19.6 mVms
P213 M / F % of the T-loop potential located in the basal hemisphere, ie, in the octants 5–8 M: ≤39%; F: ≤95%
P220 M / F Median angle alpha of the vector pointing from the first point of the R-loop to the point M: < –130° or >45°
10 ms after ventricular depolarisation commences, ie, the initial orientation of the R-loop F: < –126° or >56°
P273 F Mean potential per ms of the T-loop that lies in octant 5 ≤0.10 mV
P280* F Maximal potential of the T-loop that lies in octant 7 ≤0.19 mV  
M: men; F: women; SD: standard deviation; * variables removed after prospective evaluation of the diagnostic score
Table 1
Diagnostic cariables
in cardiogoniometry.
Figure 6
The distribution of measured values is given for one exemplary variable measured in women (above) and men (below) and
for the global score (retrospective cohort). Values are sorted from the lowest to the highest. The ordinate corresponds to the
measured values. Lowest and highest measured values are indicated on the right in grey. One vertical line is drawn for each
patient. Green lines indicate patients without significant coronary artery stenoses. Yellow lines indicate patients with one
 vessel disease. Red lines indicate patients with two or three vessel disease. The sensitivity and specificity for each individual
variable are given on the right side. The numbers in parentheses indicate false negatives (above left), true positives (above
right), true negatives (below left), and false positives (below right). Red horizontal bars indicate pathological ranges for men
(upper bar) and women (lower bar).
P154
women
Total score
women
P213
men
Total score
men
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By using the median of heartbeats recorded over 15 sec-
onds (excluding premature beats), the median potential
course is obtained (figure 4).
The projections of each vector and, in particular, the
maximal vectors of each loop on a globe surrounding the
heart, with the origin of the coordinate system in its cen-
tre, are defined by two angles. The angle alpha defines
the degree of longitude (the “meridian”), ie, how much
anterior or posterior to the plane (defined by the y- and
z-axes) the vector lies (figures 2 and 3). The angle alpha
of a vector that lies in the y-axis and points to the apex is
defined as 90°. Points on the apical hemisphere have pos-
itive values for the angle alpha (0° to 180°); points on the
basal hemisphere have negative values for the angle alpha
(0° to –180°). The angle beta defines the degree of lati-
tude, ie, how much a vector lies above or below the OSP
(defined by the axes x and y). Positive values for beta indi-
cate a vector that points under the OSP (xy-plane); nega-
tive values are given for a beta that points above this
plane (figures 2 and 3).
The coordinate system of the three orthogonal axes
divides the space in eight octants (figure 3): Octants 1 to
4 are apical, 5 to 8 are basal. Octants 2, 4, 6, and 8 are an-
terior; octants 1, 3, 5, and 7 are posterior. Octants 1, 2, 5,
and 6 are inferior, and octants 3, 4, 7, and 8 are superior.
Men Women
Retrospective Prospective Retrospective Prospective
Number of patients 307 216 154 116
Age (years) 61 (11) 61 (12) 65 (10) 66 (12)
Height (cm) 173 (7) 173 (10) 161 (6) 161 (6)
Weight (kg) 82 (12) 81 (12) 70 (15) 71 (16)
Body mass index (kg/m2) 27 (4) 27 (8) 27 (6) 27 (6)
Pathological coronary angiography 195 158 69 49
Three vessel disease 63 45 24 7
Two vessel disease (RCA+LAD) 17 19 6 8
Two vessel disease (RCA+LCX) 11 13 3 4
Two vessel disease (LAD+LCX) 25 20 10 5
Single vessel disease (RCA) 24 20 7 4
Single vessel disease (LAD) 37 20 13 12
Single vessel disease (LCX) 12 8 3 3
Detailed information not available 6 13 3 6
Values are given as mean (standard deviation). For coronary angiography results, numbers of patients are given. 
Left main artery stenosis was counted as two vessel disease. RCA: right coronary artery. LAD: left anterior descending coronary artery.
LCX: left circumflex coronary artery.
Table 2
Patient characteristics
and results of coro-
nary angiography.
Men Women All
Retrospective Prospective Retrospective Prospective Retrospective Prospective
CGM Sensitivity 74% 65% 71% 61% 73% 64%
Specificity 86% 84% 88% 79% 87% 82%
Positive predictive value 90% 92% 83% 68% 88% 85%
Negative predictive value 65% 47% 79% 74% 71% 58%
ECG Sensitivity 45% 53% 57% 54% 49% 53%
Specificity 83% 81% 77% 71% 81% 75%
Positive predictive value 72% 88% 63% 57% 69% 78%
Negative predictive value 60% 39% 72% 69% 64% 51%
The gold standard used to assess CAD was coronary angiography.
Table 3
Sensitivity, speci-
ficity, positive and
negative predictive
values of cardiogo-
niometry and ECG.
CGM score
0 –1 –2 –3 –4 ≤–5
negative positive positive positive positive positive
Retrospective cohort Men Normal 96 8 2 2 3 1
CAD+ 51 60 34 22 8 20
Women Normal 75 5 3 2 0 0
CAD+ 20 20 13 7 5 4
Prospective cohort Men Normal 49 4 3 0 1 1
CAD+ 55 35 27 11 12 18
Women Normal 53 6 6 1 0 1
CAD+ 19 21 5 3 1 0
The gold standard used to assess CAD was coronary angiography. CAD: coronary artery disease
Table 4
Numbers of patients
according to coro-
nary angiography
 results and cardiogo-
niometry scores.
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Choice of variables for the diagnostic score
Using the CGM recordings from 461 patients, a dia g -
nostic score was retrospectively derived to identify pa-
tients with CAD. The diagnostic score was developed in a
two-step procedure. Firstly, among the 350 variables de-
scribing the cardiogoniometric loops that were measured
in each patient, we used only those for which limits of
normal ranges could be defined, ie, variables with di-
chotomising quality that showed ranges in which only –
or mostly – pathological cases were found, and no meas-
ure from a patient with a normal coronary angiogram.
No univariate statistical tests were used for choosing di-
agnostic variables. In a second step, variables were
grouped according to their electrophysiological aspects
(time course, potential, direction of vectors, R or T val-
ues, beat-to-beat variability), and redundant variables
were eliminated. Variables that were physiologically not
plausible were discarded. CAD may alter the surface po-
tential of the global cardiac activity in different ways, de-
pending on the affected area of the myocardium. There-
fore, a combination score of penalizing variables has been
used. The number of variables used for the score was de-
liberately restricted in order to avoid over-determination.
Several variables, as described below, were retained (13
for men and 10 for women) to formulate a diagnostic
score (table 1). For each value outside the normal range, a
negative point was given (figure 6). Normal limits for the
variables were defined so as to ensure the best discrimina-
tion between normal and pathologic cases. When the
score did not equal 0, a CGM diagnosis of CAD was
made. No positive points were given. Coronary arteriog-
raphy was used as the gold standard for the presence or
absence of CAD. For the purpose of this study, an empir-
ical cut-off value of 50% was chosen for a stenosis in one
of the three main coronary arteries to define CAD. How-
ever, 96% of all patients who were rated as having CAD
had stenoses 075% or multiple 50% stenoses in series.
Prospective CGM scoring was performed automatically
and independent of the assessment of the coronary an-
giogram. All assessors were blinded as to the respective
results from the other method.
ECGs used the traditional 12-lead standard record-
ings taken in the supine position at rest and in accordance
with the recommendations of the American Heart Asso-
ciation [12]. The ECGs were rated on the basis of the
Utrecht ECG Coding System [13, 14].
Figure 7
Diagnostic sensitiv-
ity, specificity, and
accuracy of CGM and
ECG.
Results
Characteristics for the 461 patients (154
women) in the retrospective cohort and the 332
(116 women) in the prospective cohort are given
in table 2.
Results from the retrospective cohort
Coronary angiography showed stenoses in
195 men (64%) and 69 (45%) women. The an-
giography results are given in table 2. Detailed in-
formation was not available for six men and three
women with pathological coronary angiography.
Four women and thirteen men had acute or suba-
cute anterior wall myocardial infarction. Six
women and twenty men had acute or subacute
 posterior wall myocardial infarction. Using one
non-invasive recording at rest, CGM correctly
 diagnosed 240 men (78%) and 124 women (81%)
for the presence or absence of CAD. This results
in a higher CAD diagnostic sensitivity with the
CGM than with the ECG; both methods show
similar specificity (table 3).
For all assessed values, the ranges of patients
with and without CAD overlapped. CGM was
considered positive if at least one value lay beyond
the defined limit of normality for the respective
variable. The combination of thirteen (men), re-
spectively ten (women), variables was necessary to
derive the diagnostic score. The CGM scores for
men and women with and without coronary artery
stenoses are given in table 4.
Prospective validation of the diagnostic score
Coronary angiography showed stenoses in
158 men (73%) and 49 (42%) women. The an-
giography results are given in Table 2. Detailed
information was not available for nine men and
four women with single vessel disease and four
men and two women with two vessel disease. Two
men had acute or subacute anterior wall myocar-
dial infarction. Prospective application of the
CGM score for identification of patients with
coronary artery disease resulted in an overall dia g -
nostic sensitivity of 64%, and specificity of 82%
(table 3). The CGM scores are given in table 4.
For comparison, the overall diagnostic sensitivity
and specificity of the ECG were 53% and 75%,
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respectively (table 3), in the prospective cohort.
The diagnostic sensitivity, but not specificity, was
significantly better for CGM than for ECG (p
<0.007). Overall prospective diagnostic accuracy
was better with CGM than with ECG (p <0.003):
71% (men 70%, women 72%) for CGM and 62%
(men 61%, women 64%) for ECG (figure 7). Re-
view of the usefulness of the chosen variables in
men confirmed the high diagnostic value of all
variables but P136.
Among the nine male patients who were
falsely identified by CGM as having ischaemia,
four had cardiomyopathy (CMP) (one alcoholic
CMP, two dilatative CMP, one CMP of unknown
origin), one had left ventricular hypertrophy, one
had giant coronary arteries, one had a muscle
bridge over the LAD with “milking,” and one had
experienced sinus tachycardia with elevation of
troponin before the CGM recording.
The diagnostic value of variables used among
women proved excellent for all variables but
P280, which led to only false positive results and
must therefore be invalidated.
Among the fourteen female false positive
cases, two had left ventricular hypertrophy, one
had a muscle bridge over the LAD with “milking,”
one had an acute myocardial infarction due to hy-
povolaemic shock, one had severe cor pulmonale
with elevated troponin and postulated ischaemia
due to congestion, one had troponin-positive
acute myocarditis, and one had circumscript
 antero-lateral hypokinesia with open coronary
 arteries, suggesting myocardial infarction due to a
thrombus that resolved prior to angiography.
Thus, in seven patients, a possible cause for myo -
cardial ischaemia in the absence of CAD could be
identified.
Discussion
Non-invasive detection of myocardial is-
chaemia can be performed using surface ECG 
[15, 16], echocardiography and scintigraphy,
which has largely been replaced by newer, expen-
sive techniques employing radionuclide imaging
[17] solely available at tertiary centres. The sensi-
tivity of diagnostic methods that are performed at
rest and yet available outside tertiary centres is
low, and stress testing is therefore required to im-
prove the diagnostic yield [18, 19]. Thus, surface
ECG is currently the only inexpensive and
widely-available method for non-invasive out-of-
clinic assessment of myocardial ischaemia at rest.
Although vectorcardiography has never gained
broad acceptance in general clinical practice, the
contribution of a third dimension in the analysis
of cardiac electrical potentials is obvious [20, 3].
Nevertheless, this information cannot be ob-
tained accurately from a conventional 12-lead-
ECG because intercalated resistances distort the
information, and because ECG leads do not form
an orthogonal system. We present here a vector-
cardiographic method that is easier to record than
the conventional ECG (4 leads instead of 12),
clearly displays accurate three-dimensional sur-
face electrophysiological information and pro-
vides automated diagnostic evaluation of digital -
ised measurements. The variables used in the
CGM score serve to identify the abnormal spatial
localization of cardiac potentials and abnormal
beat-to-beat variability. The use of these variables
is plausible since alterations of repolarisation and
depolarisation potentials are commonly used in
the ECG diagnosis of IHD [21, 22], eg, a negative
T-wave in the ECG corresponds to a high 
percentage of basal T-loop potentials (P213 in
CGM). Two CGM variables, P136 and P280, ini-
tially thought helpful for diagnosis proved non-
contributory to the prospective assessment. The
reasons for this are unclear; further studies with
greater patient numbers and stratification accord-
ing to the distribution of the affected myocardial
areas are thus warranted.
This study has several limitations. Firstly,
there may be a referral bias, as all patients were
sent to a tertiary medical centre for invasive car-
diac assessment due to suspected myocardial 
ischaemia. Our results may therefore not be 
generalised to other populations. Secondly, the
angiographic findings provide morphological 
information on coronary artery stenoses that only
partly correlates with the presence and extent of
ischaemia [23–25]. However, even though overt
ischaemia may be absent at rest in asymptomatic
patients with coronary artery stenoses, CGM
showed a 64% sensitivity in identifying CAD pa-
tients. We hypothesize that, even in the absence of
frank ischaemia, subtle electrophysiological alter-
ations occur in CAD that may be detected by
CGM, thereby identifying patients with silent
myocardial ischaemia [26, 27]. Moreover, there
were eleven false positive patients (seven women)
with plausible reasons for myocardial ischaemia in
the absence of significant coronary stenoses
(tachycardia with troponin elevation, myocardial
bridges [28], giant coronary arteries [29], left 
ventricular hypertrophy, myocardial infarction,
troponin-positive acute cor pulmonale). If these
cases are excluded from the analysis, specificity
would rise to 91% in men and 88% in women.
In summary, a CGM score for non-invasive
identification of patients with CAD has been 
retrospectively established and prospectively vali-
dated in a cohort of patients in a university hospi-
tal setting.
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Based on these CGM results achieving a dia g -
nostic sensitivity higher than the ECG with a
comparable diagnostic specificity, we conclude
that CGM may be a helpful tool in identifying
CAD. As it is easy to apply, non-invasive, provides
an automated score and can be performed at rest,
we believe that it may become an inexpensive ad-
dition to the cardiological diagnostic armamen-
tarium, possibly useful for early CAD diagnosis as
well as in patients who do not tolerate exercise
testing. Further studies on the diagnostic useful-
ness of CGM in a general population with a lower
pretest probability for CAD are warranted.
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